Qiagen delivered a strong start to 2025, exceeding expectations for net sales and earnings. Key product lines showed robust growth, and profitability improved significantly. While challenges remain in the China market and cautious customer spending, the company reaffirmed its full-year outlook and expanded shareholder return options, indicating confidence in its strategy and execution.

Company Guidance -

Q2 2025

In the Q1 2025 earnings call, Qiagen reported exceeding their outlook with net sales of $483 million, reflecting a 7% increase at constant exchange rates (CER) compared to Q1 2024. Adjusted diluted earnings per share were $0.50 at CER, surpassing the expected minimum of $0.50. The company reaffirmed its full-year 2025 outlook, projecting around 4% sales growth at CER, and upgraded its adjusted earnings per share target to approximately $2.35 at CER, up $0.07 from the initial guidance. Key growth drivers included QIAstat's double-digit sales increase due to new panel launches, QuantiFERON's strong performance with double-digit sales growth, and the momentum in QIAcuity's digital PCR platform. Qiagen also highlighted its strategic initiatives, including the introduction of a cash dividend and a proposed $500 million synthetic share repurchase, as part of its goal to return at least $1 billion to shareholders by 2028.

Exceeded Q1 2025 Outlook

Qiagen delivered net sales of $483 million, representing a 7% increase at constant exchange rates (CER) compared to Q1 2024. Adjusted diluted earnings per share were $0.50, exceeding the outlook for at least $0.50.

Strong Performance of Key Products

QIAstat achieved double-digit sales growth, QuantiFERON tuberculosis test delivered another strong quarter of double-digit sales growth, and QIAcuity digital PCR platform continued to build momentum in high-growth fields.

Increased Profitability

Adjusted operating income margin rose to 29.8% of sales, up more than four percentage points from Q1 2024, driven by a favorable shift towards consumables and bioinformatics solutions.

Reaffirmed Full Year 2025 Outlook

Qiagen expects around 4% sales growth at CER, with an upgraded target for adjusted earnings per share of about $2.35, up $0.07 from the initial outlook for the year.

Expansion of Shareholder Returns

Introduction of an annual cash dividend and proposal for a synthetic share repurchase of up to $500 million for consideration over an 18-month period.

Qiagen (QGEN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

QGEN Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Aug 05, 2025	2025 (Q2)	0.60 / -	0.566	―	―	―
May 07, 2025	2025 (Q1)	0.50 / 0.55	0.473	16.28% (+0.08)
Feb 05, 2025	2024 (Q4)	0.62 / 0.61	0.566	7.77% (+0.04)
Nov 06, 2024	2024 (Q3)	0.56 / 0.59	0.53	10.57% (+0.06)
Jul 31, 2024	2024 (Q2)	0.54 / 0.57	0.541	4.62% (+0.02)
Apr 29, 2024	2024 (Q1)	0.45 / 0.47	0.541	-12.57% (-0.07)
Feb 06, 2024	2023 (Q4)	0.57 / 0.57	0.562	0.71% (<+0.01)
Oct 30, 2023	2023 (Q3)	0.51 / 0.53	0.562	-5.69% (-0.03)
Aug 08, 2023	2023 (Q2)	0.53 / 0.54	0.541	0.00% (0.00)
May 03, 2023	2023 (Q1)	0.49 / 0.54	0.848	-36.20% (-0.31)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

QGEN Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
May 07, 2025	$42.41	$41.94	-1.11%
Feb 05, 2025	$43.57	$42.22	-3.10%
Nov 06, 2024	$43.64	$43.91	+0.62%
Jul 31, 2024	$44.25	$45.56	+2.96%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Qiagen NV (QGEN) report earnings?

Qiagen NV (QGEN) is schdueled to report earning on Aug 05, 2025, After Close (Confirmed).

What is Qiagen NV (QGEN) earnings time?

Qiagen NV (QGEN) earnings time is at Aug 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is QGEN EPS forecast?

QGEN EPS forecast for the fiscal quarter 2025 (Q2) is 0.6.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing